Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1995 May;86(5):460–469. doi: 10.1111/j.1349-7006.1995.tb03079.x

Establishment and Characterization of Non‐small Cell Lung Cancer Cell Lines Resistant to Mitomycin C under Aerobic Conditions

Kazuhiko Shibata 1,✉, Kazuo Kasahara 1, Takuma Bando 1, Yasuto Nakatsumi 1, Masaki Fujimura 1, Takashi Tsuruo 2, Tamotsu Matsuda 1
PMCID: PMC5920845  PMID: 7790319

Abstract

To elucidate the mechanisms of acquired resistance to mitomycin C (MMC) in non‐small cell lung cancer (NSCLC), we established two MMC‐resistant NSCLC sublines by continuous exposure to MMC, using PC‐9 as a parent cell line. The sublines, PC‐9/MC2 and PC‐9/MC4, were 6.4‐ and 10‐fold more resistant to MMC than their parent cell line, respectively, at the IC50 value as determined by MTT assay. They exhibited cross‐resistance to EO9, but were not resistant to cisplatin, vindesine, etoposide, carboquone, or KW‐2149, a novel MMC derivative. They were collaterally sensitive to adriamycin and menadione. Accumulation of the drug was decreased in the resistant sublines to about 60% of that in the parent cells. Cytosolic DT‐diaphorase (DTD) activities were decreased to 13.5±3.2 in PC9/MC2 and 1.3±0.6 in PC‐9/MC4 from 261.5±92.7 nmol/min/mg protein in the parent PC‐9. NADH:cytochrome b5 reductase activities in both of the resistant cell lines were significantly decreased as compared to that in the parent cell line. Addition of dicumarol resulted in a two‐fold increase in IC50 value in PC‐9, whereas the IC50 value showed no change in PC‐9/MC4. Moreover, dicumarol did not affect the sensitivities to KW‐2149 but decreased the sensitivities to EO9 in both the parent and the resistant cell lines. Formation of an alkylating metabolite was significantly decreased in the resistant cells, in parallel to the degree of resistance. We concluded that deficient drug activation due to decreased DTD activity was important as a mechanism of resistance to MMC in PC‐9, a relatively DTD‐rich NSCLC cell line.

Keywords: Mitomycin C, EO9, KW‐2149, DT‐diaphorase, Dicumarol

Full Text

The Full Text of this article is available as a PDF (607.0 KB).

REFERENCES

  • 1).Verweij , J. , den Hartigh , J. and Pinedo , H. M.Antitumor antibiotics . In “ Cancer Chemotherapy: Principles and Practice ,” pp. 382 – 396 ( 1990. ). J. B. Lippincott Company; , Philadelphia . [Google Scholar]
  • 2).Dorr , R. T. , Liddil , J. D. , Trent , J. M. and Dalton , W. S.Mitomycin C resistant L1210 leukemia cells: association with pleiotropic drug resistance . Biochem. Pharmacol. , 36 , 3115 – 3120 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 3).Dulhanty , A. M. , Li , M. and Whitmore , G. F.Isolation of Chinese hamster ovary cell mutants deficient in excision repair and mitomycin C bioactivation . Cancer Res. , 49 , 117 – 122 ( 1989. ). [PubMed] [Google Scholar]
  • 4).Dusre , L. , Rajagopalan , S. , Eliot , H. M. , Covey , J. M. and Sinha , B. K.DNA interstrand cross‐link and free radical formation in a human multidrug‐resistant cell line from mitomycin C and its analogues . Cancer Res. , 50 , 648 – 652 ( 1990. ). [PubMed] [Google Scholar]
  • 5).Schelber , S. A. , Duval , D. L. and Pardini , R. S.Relationship between glutathione S‐transferase activity and mitomycin C response in two human colon carcinoma cell lines . Proc. Am. Assoc. Cancer Res. , 33 , 461 ( 1992. ). [Google Scholar]
  • 6).Siegel , D. , Gibson , N. W. , Preusch , P. C. and Ross , D.Metabolism of mitomycin C by DT‐diaphorase: role in mitomycin C‐induced DNA damage and cytotoxicity in human colon carcinoma cells . Cancer Res. , 50 , 7483 – 7489 ( 1990. ). [PubMed] [Google Scholar]
  • 7).Hoban , P. R. , Walton , M. I. , Robson , C. N. , Godden , J. , Stratford , I. J. , Workman , P. , Harris , A. L. and Hickson , I. D.Decreased NADPH:cytochrome P‐450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions . Cancer Res. , 50 , 4692 – 4697 ( 1990. ). [PubMed] [Google Scholar]
  • 8).Traver , R. D. , Horikoshi , T. , Danenberg , K. D. , Stadlbauer , T. H. W. , Danenberg , P. V. , Ross , D. and Gibson , N. W.NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT‐diaphorase activity and mitomycin sensitivity . Cancer Res. , 52 , 797 – 802 ( 1992. ). [PubMed] [Google Scholar]
  • 9).Workman , P.Keynote address: bioreductive mechanisms . Int. J. Radiat. Oncol. Biol. Phys. , 22 , 631 – 637 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 10).Dorr , R. T.New findings in the pharmacokinetic, metabolic, and drug‐resistance aspects of mitomycin C . Semin. Oncol. , 15 , 32 – 41 ( 1988. ). [PubMed] [Google Scholar]
  • 11).Doroshow , J. H.Reductive activation of mitomycin C: a delicate balance . J. Natl. Cancer Inst. , 84 , 1138 – 1139 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 12).Keyes , S. R. , Fracasso , P. M. , Heimbrook , D. C. , Rockwell , S. , Sliger , S. G. and Sartorelli , A. C.Role of NADPH:cytochrome c reductase and DT‐diaphorase in the biotransformation of mitomycin C . Cancer Res. , 44 , 5638 – 5643 ( 1984. ). [PubMed] [Google Scholar]
  • 13).Pan , S. , Andrews , P. A. , Glover , C. J. and Bachur , N. R.Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH‐cytochrome P‐450 reductase and xanthine oxidase . J. Biol. Chem. , 259 , 959 – 966 ( 1984. ). [PubMed] [Google Scholar]
  • 14).Begleiter , A. , Robotham , E. and Leith , M. K.Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT‐diaphorase) in activation of mitomycin C under hypoxia . Mol. Pharmacol. , 41 , 677 – 682 ( 1992. ). [PubMed] [Google Scholar]
  • 15).Gustafson , D. J. and Pristos , C. A.Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors . J. Natl. Cancer Inst. , 84 , 1180 – 1185 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 16).Siegel , D. , Gibson , N. W. and Ross , D.DT‐diaphorase mediated activation of mitomycin C to DNA crosslinking species dependent on pH . Proc. Am. Assoc. Cancer Res. , 33 , 404 ( 1992. ). [Google Scholar]
  • 17).Siegel , D. , Beall , H. , Senekowitsch , C. , Kasai , M. , Arai , H. , Gibson , N. W. and Ross , D.Bioreductive activation of mitomycin C by DT‐diaphorase . Biochemistry , 31 , 7879 – 7885 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 18).Ernster , L.DT‐diaphorase . Methods Enzymol. , 10 , 309 – 317 ( 1967. ). [Google Scholar]
  • 19).Ernster , L.DT diaphorase: a historical review . Chem. Scr. , 27A , 1 – 13 ( 1987. ). [Google Scholar]
  • 20).Workman , P. , Walton , M. I. , Powis , G. and Schlager , J. J.DT‐diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs ? Br. J. Cancer , 60 , 800 – 802 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21).Schlager , J. J. and Powis , G.Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD (P) H: (quinone‐acceptor) oxidoreductase . Cancer Chemother. Pharmacol. , 22 , 126 – 130 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 22).Marshall , R. , Rauth , A. M. and Paterson , M.Reply to the letter from Workman et al.Br. J. Cancer , 60 , 803 ( 1989. ). [Google Scholar]
  • 23).Bligh , H. F. J. , Bratoszek , A. , Robson , C. N. , Hickson , I. D. , Kasper , C. B. , Beggs , J. D. and Wolf , C. R.Activation of mitomycin C by NADPH:cytochrome P‐450 reductase . Cancer Res. , 50 , 7789 – 7792 ( 1990. ). [PubMed] [Google Scholar]
  • 24).Doroshow , J. , Akman , S. and Forrest , G.Effect of DT‐diaphorase overexpression on mitomycin C toxicity for Chinese hamster ovary cells . Proc. Am. Assoc. Cancer Res. , 33 , 507 ( 1992. ). [Google Scholar]
  • 25).Dulhanty , A. M. and Whitmore , G. F.Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT‐diaphorase . Cancer Res. , 51 , 1860 – 1865 ( 1991. ). [PubMed] [Google Scholar]
  • 26).Begleiter , A. , Robotham , E. , Lacey , G. and Leith , M. K.Increased sensitivity of quinone resistant cells to mitomycin C . Cancer Lett. , 45 , 173 – 176 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 27).Marshall , R. S. , Paterson , M. C. and Rauth , A. M.Deficient activation by a human cell strain leads to mitomycin C resistance under aerobic but not hypoxic conditions . Br. J. Cancer , 59 , 341 – 346 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28).Bando , T. , Kasahara , K. , Shibata , K. , Nakatsumi , Y. , Fujimura , M. and Matsuda , T.Role of DT‐diaphorase as a determinant of sensitivity to mitomycin analogues in non‐small cell lung cancer cell lines . Int. J. Oncol. , 5 , 819 – 825 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 29).Arai , H. and Kasai , M.Synthesis of [C6‐CH3‐14C]‐ and [C6‐CH3‐3H3]mitomycin C . J. Labelled Compd. Radiopharm. , 29 , 903 – 908 ( 1991. ). [Google Scholar]
  • 30).Mosmann , T.Rapid calorimetric assay for cellular growth and survival: application of proliferation and cytotoxic assay . J. Immunol. Methods , 65 , 55 – 63 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 31).Benson , A. M. , Hunkeler , M. J. and Talalay , P.Increase of NAD(P)H: quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity . Proc. Natl. Acad. Sci. USA , 77 , 5216 – 5220 ( 1980. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32).Phillips , A. H. and Langdon , R. G.Hepatic triphosphopyridine nucleotide‐cytochrome c reductase: isolation, characterization, and kinetic studies . J. Biol. Chem. , 237 , 2652 – 2660 ( 1962. ). [PubMed] [Google Scholar]
  • 33).Yubisu , T. and Takeshita , M.Purification and properties of soluble NADH‐cytochrome b5 reductase of rabbit erythrocytes . J. Biochem. , 91 , 1467 – 1477 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 34).Kennedy , K. A. , Rockwell , S. and Sartorelli , A. C.Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells . Cancer Res. , 40 , 2356 – 2360 ( 1980. ). [PubMed] [Google Scholar]
  • 35).Keyes , S. R. , Rockwell , S. and Sartorelli , A. C.Correlation between drug uptake and selective toxicity of porfiromycin to hypoxic EMT6 cells . Cancer Res. , 47 , 5654 – 5657 ( 1987. ). [PubMed] [Google Scholar]
  • 36).Walton , M. I. , Smith , P. J. and Workman , P.The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT‐diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9 . Cancer Commun. , 3 , 199 – 206 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 37).Bailey , S. M. , Sugget , N. , Walton , M. I. and Workman , P.Structure‐activity relationships for DT‐diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones . Int. J. Radiat. Oncol. Biol. Phys. , 22 , 649 – 653 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 38).Walton , M. I. , Bibby , M. C. , Double , J. A. , Plumb , J. A. and Workman , P.DT‐diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and human colon carcinomas . Eur. J. Cancer , 28A , 1597 – 1600 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 39).Walton , M. I. , Sugget , N. and Workman , P.The role of human and rodent DT‐diaphorase in the reductive metabolism of hypoxic cell cytotoxins . Int. J. Radiat. Oncol. Biol. Phys. , 22 , 643 – 647 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 40).Kono , M. , Saitoh , Y. , Kasai , M. , Sato , A. , Shirahata , K. , Morimoto , M. and Ashizawa , T.Synthesis and antitumor activity of a novel water soluble mitomycin C analogue; 7‐N‐ { (2‐ { [2‐ (γ‐L‐glutamylamino) ethyl] dithio} ethyl)} ‐mitomycin C . Chem. Pharm. Bull. , 37 , 1128 – 1130 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 41).Morimoto , M. , Ashizawa , T. , Ohno , H. , Azuma , M. , Kobayashi , E. , Okabe , M. , Gomi , K. , Kono , M. , Saitoh , Y. , Kanda , Y. , Arai , H. , Sato , A. , Kasai , M. and Tsuruo , T.Antitumor activity of 7‐N‐{{2‐{[2‐(γ‐L‐glutamylamino)ethyl]dithio} ethyl} } mitomycin C . Cancer Res. , 51 , 110 – 115 ( 1991. ). [PubMed] [Google Scholar]
  • 42).Lee , J. , Naito , M. and Tsuruo , T.Nonenzymatic reductive activation of 7‐N‐ {{2‐{[2‐(γ‐L‐glutamylamino)ethyl]‐dithio} ethyl}} mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C‐resistant tumor cells . Cancer Res. , 54 , 2398 – 2403 ( 1994. ). [PubMed] [Google Scholar]
  • 43).He , Q. and Tomasz , M.A novel reductive activation mechanism of mitomycin analogs containing a disulfide group in their 7‐position substituent . Proc. Am. Assoc. Cancer Res. , 35 , 336 ( 1994. ). [Google Scholar]
  • 44).Chakrabarty , S. , Danels , Y. J. , Long , B. H. , Willson , J. K. V. and Brattain , M. G.Circumvention of deficient activation in mitomycin C‐resistant human colonic carcinoma cells by the mitomycin C analogue BMY25282 . Cancer Res. , 46 , 3456 – 3458 ( 1986. ). [PubMed] [Google Scholar]
  • 45).Willson , J. K. V. , Long , B. H. , Chakrabarty , S. , Brattain , D. E. and Brattain , M. G.Effects of BMY 25282, a mitomycin C analogue, in mitomycin C‐resistant human colon cancer cells . Cancer Res. , 45 , 5281 – 5286 ( 1985. ). [PubMed] [Google Scholar]
  • 46).Nakamura , T. , Tatsumi , K. , Fukai , M. , Sasada , M. , Higuchi , T. , Inagaki , A. , Sawada , H. , Shirakawa , S. and Wakisaka , G.Mode of action of carbazilquinone in leukemic cells . Acta Haematol. Jpn. , 37 , 1 – 8 ( 1974. )( in Japanese ). [PubMed] [Google Scholar]
  • 47).Marshall , R. S. , Paterson , M. C. and Rauth , A. M.Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancerprone individual . Biochem. Pharmacol. , 41 , 1351 – 1360 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 48).Malkinson , A. M. , Siegel , D. , Forrest , G. L. , Gazdar , A. F. , Oie , H. K. , Chan , D. C. , Bunn , P. A. , Mabry , M. , Dykes , D. J. , Harrison , S. D. and Ross , D.Elevated DT‐diaphorase activity and messenger RNA content in human non‐small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin C . Cancer Res. , 52 , 4752 – 4757 ( 1992. ). [PubMed] [Google Scholar]
  • 49).Keyes , S. R.Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells . Cancer Res. , 49 , 3310 – 3313 ( 1989. ). [PubMed] [Google Scholar]
  • 50).Thor , H. , Smith , M. T. , Hartzell , P. , Bellomo , G. , Jewell , S. A. and Orrenius , S.The metabolism of menadine (2‐methyl‐1,4‐naphthoquinone) by isolated hepatocytes . J. Biol. Chem. , 257 , 12419 – 12425 ( 1982. ). [PubMed] [Google Scholar]
  • 51).Kasahara , K. , Shibata , K. , Bando , T. , Numata , Y. , Fujimura , M. and Matsuda , T.DT‐diaphorase as a determinant of sensitivity to adriamycin in non‐small cell lungcancer cell lines . Int. J. Cancer , 59 , 204 – 207 ( 1994. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES